News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Tripos Reports Third-Quarter 2006 Financial Results And Provides Update On Strategic Alternatives Process
November 15, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ST. LOUIS, Mo.--(BUSINESS WIRE)--Tripos, Inc. (Nasdaq:TRPS), a leading provider of drug discovery chemistry and informatics products and services, today announced financial results for the third quarter of the fiscal year ended Sept. 30, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
·
1 min read
·
Jef Akst
Mergers & acquisitions
Serapha takes reverse merger route to Nasdaq with $230M and gene editor from China
June 24, 2026
·
2 min read
·
Tristan Manalac
Business
Takeda enters transitional year as new CEO seeks return to growth
June 24, 2026
·
2 min read
·
Tristan Manalac
Venture capital
Ollin parlays Vabysmo beat into $330M raise to test eye disease drug in Phase 3
June 24, 2026
·
1 min read
·
Annalee Armstrong